Missing/wrong data?
Log in to edit
Incidence of major and clinically relevant non-major bleeding in patients prescribed rivaroxaban for stroke prevention in non-valvular atrial fibrillation in secondary care: Results from the Rivaroxaban Observational Safety Evaluation (ROSE) study
scientific article published on 09 October 2020
Author/s
author: Alison Evans, Vicki Osborne, Saad Shakir
Work details
Publication date
October 9, 2020
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.